US Patent

US12171772 — Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives

Composition of Matter · Assigned to Melinta Subsidiary Corp · Expires 2031-08-08 · 5y remaining

Vulnerability score 23/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects the use of cyclic boronic acid ester derivatives as therapeutic agents.

USPTO Abstract

Disclosed herein are antimicrobial compounds compositions, pharmaceutical compositions, the use and preparation thereof. Some embodiments relate to cyclic boronic acid ester derivatives and their use as therapeutic agents.

Drugs covered by this patent

Patent Metadata

Patent number
US12171772
Jurisdiction
US
Classification
Composition of Matter
Expires
2031-08-08
Drug substance claim
Yes
Drug product claim
No
Assignee
Melinta Subsidiary Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.